Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma

Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Scott P., Song, Daniel Y., Pierorazio, Phillip M., Allaf, Mohamad E., Gorin, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658408/
https://www.ncbi.nlm.nih.gov/pubmed/26640488
http://dx.doi.org/10.1155/2015/547143
_version_ 1782402508232065024
author Campbell, Scott P.
Song, Daniel Y.
Pierorazio, Phillip M.
Allaf, Mohamad E.
Gorin, Michael A.
author_facet Campbell, Scott P.
Song, Daniel Y.
Pierorazio, Phillip M.
Allaf, Mohamad E.
Gorin, Michael A.
author_sort Campbell, Scott P.
collection PubMed
description Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this review, we explore the current literature on SABR for the primary treatment of RCC and make recommendations for future studies so that an accurate comparison between SABR and other ablative therapies may be conducted.
format Online
Article
Text
id pubmed-4658408
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46584082015-12-06 Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma Campbell, Scott P. Song, Daniel Y. Pierorazio, Phillip M. Allaf, Mohamad E. Gorin, Michael A. J Oncol Review Article Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this review, we explore the current literature on SABR for the primary treatment of RCC and make recommendations for future studies so that an accurate comparison between SABR and other ablative therapies may be conducted. Hindawi Publishing Corporation 2015 2015-11-11 /pmc/articles/PMC4658408/ /pubmed/26640488 http://dx.doi.org/10.1155/2015/547143 Text en Copyright © 2015 Scott P. Campbell et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Campbell, Scott P.
Song, Daniel Y.
Pierorazio, Phillip M.
Allaf, Mohamad E.
Gorin, Michael A.
Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title_full Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title_fullStr Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title_full_unstemmed Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title_short Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
title_sort stereotactic ablative radiotherapy for the treatment of clinically localized renal cell carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658408/
https://www.ncbi.nlm.nih.gov/pubmed/26640488
http://dx.doi.org/10.1155/2015/547143
work_keys_str_mv AT campbellscottp stereotacticablativeradiotherapyforthetreatmentofclinicallylocalizedrenalcellcarcinoma
AT songdaniely stereotacticablativeradiotherapyforthetreatmentofclinicallylocalizedrenalcellcarcinoma
AT pieroraziophillipm stereotacticablativeradiotherapyforthetreatmentofclinicallylocalizedrenalcellcarcinoma
AT allafmohamade stereotacticablativeradiotherapyforthetreatmentofclinicallylocalizedrenalcellcarcinoma
AT gorinmichaela stereotacticablativeradiotherapyforthetreatmentofclinicallylocalizedrenalcellcarcinoma

Ejemplares similares